BioVie Inc. - Common stock — 재무제표 (NASDAQ:BIVI) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 6.05 M20.11 M35.1 M25.21 M21.56 M 총 부채 996.37 K16.44 M19.76 M9.7 M2.55 M 자본금 총액 5.05 M3.67 M15.34 M15.51 M19.01 M 총 부채 및 주주자본 6.05 M20.11 M35.1 M25.21 M21.56 M 총부채 012.14 M14.33 M5.7 M— 순부채 -4.51 M-6.5 M-5.13 M-18.14 M—

뉴스

BioVie Inc. (BIVI) Discusses Bezisterim's Mechanism of Action and Its Potential in Addressing Parkinson's Disease Pathology Transcript

BioVie Inc. (BIVI) Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID Transcript

바이오뷰, 파킨슨병 치료제 임상 시험 등록 완료

BioVie completes enrollment for Parkinson’s drug trial

What Makes BioVie (BIVI) a New Buy Stock

BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease Transcript

BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease - Slideshow (NASDAQ:BIVI) 2025-12-09

짐 랭, Halozyme 이사회 이사로 선출

BioVie, 주주총회서 주식 보상 계획안 승인

BioVie shareholders approve amendment to equity incentive plan at annual meeting

BioVie, 연례 회의서 이사진 선임 및 주식 계획 승인

BioVie shareholders approve board nominees and equity plan at annual meeting